RPV - ETF AI Analysis
Top Page
Invesco S&P 500 Pure Value ETF (RPV)
RPV, the Invesco S&P 500 Pure Value ETF, earns a solid overall rating largely because several of its key holdings, like Phillips 66 and Valero Energy, show strong financial performance, robust cash flow, and supportive earnings outlooks that help underpin the fund’s quality. At the same time, weaker names such as Dow Inc., with revenue and profitability challenges and a bearish trend, may drag on the rating, and the fund’s meaningful exposure to economically sensitive energy and industrial businesses is a key risk if market or commodity conditions worsen.
RPV vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.75B
- Region
- North America
- Expense Ratio
- 0.35%
- Beta
- 0.56
- Issuer
- Invesco
- Inception Date
- Mar 01, 2006
- Dividend Yield
- 2.10%
- Asset Class
- Equity
- Index Tracked
- S&P 500/Citigroup Pure Value
RPV Summary
Invesco S&P 500 Pure Value ETF (RPV) is a fund that follows the S&P 500 Pure Value Index, focusing on large U.S. companies that appear cheaply priced compared with their business fundamentals. It mainly holds well-known names like Target and Valero Energy, along with firms in health care, financials, and consumer staples. Investors might consider RPV if they want diversification across many established companies and believe undervalued “value” stocks could perform well over time. A key risk is that value stocks can lag the broader market for long periods, so the ETF’s price can go up and down and may underperform growth-focused funds.
How much will it cost me?
This ETF has an expense ratio of 0.35%, which means you’ll pay about $3.50 per year for every $1,000 you invest. That’s a bit higher than the average low-cost index ETF because it follows a more specialized “pure value” strategy rather than a plain-vanilla broad market index.
What would affect this ETF?
RPV could benefit if value stocks come back into favor, especially in the U.S. health care, financial, and energy sectors where it is heavily invested, and if the overall economy grows steadily without sharp downturns. On the negative side, rising interest rates, weaker consumer spending, or tighter regulations on health care and energy companies could hurt its top holdings like Centene, Humana, and major refiners, weighing on future performance.
RPV Top 10 Holdings
RPV leans heavily into U.S. value names, with health care and energy doing much of the heavy lifting. Hewlett Packard Enterprise has been a standout, riding momentum in networking and AI, while refiners like Valero, Marathon Petroleum, and Phillips 66 give the fund a strong energy backbone that’s been steadily pushing returns higher. On the softer side, CVS Health has been lagging and acting like a brake, and food giants Archer Daniels Midland and Bunge are more mixed, reflecting choppy global demand. Overall, it’s a concentrated bet on U.S. large-cap value, not flashy growth.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 CNC | Centene | 2.81% | $48.91M | $33.94B | 107.27% | 58Neutral |
 HUM | Humana | 2.48% | $43.20M | $49.82B | 41.91% | 69Neutral |
 VLO | Valero Energy | 2.05% | $35.63M | $111.53B | 122.16% | 69Neutral |
 PSX | Phillips 66 | 2.05% | $35.63M | $107.15B | 98.29% | 73Outperform |
 ADM | Archer Daniels Midland | 2.18% | $37.86M | $37.69B | 26.25% | 64Neutral |
 MPC | Marathon Petroleum | 1.98% | $34.39M | $122.43B | 122.18% | 66Neutral |
 DOW | Dow Inc | 2.12% | $36.82M | $24.45B | 31.29% | 49Neutral |
 HPE | Hewlett Packard Enterprise | 2.12% | $36.85M | $80.76B | 151.61% | 68Neutral |
 BG | Bunge Global | 2.01% | $34.90M | $19.47B | 5.12% | 66Neutral |
 CVS | CVS Health | 1.81% | $31.57M | $116.55B | 10.53% | 64Neutral |
RPV Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RPV, the sentiment is Positive. The current price of 120.25 is above the 20-day moving average (MA) of 118.41, above the 50-day MA of 119.46, and above the 200-day MA of 113.06, indicating a bullish trend. The MACD of 0.68 indicates Negative momentum. The RSI at 55.98 is Neutral, neither overbought nor oversold. The STOCH value of 65.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RPV.
RPV Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| RPV | $120.25 | $128.00(6.44% Upside) | $1.75B | 0.35% | 68Neutral |
 JAVA | $82.94 | $96.36(16.18% Upside) | $7.36B | 0.44% | 71Outperform |
 DFLV | $41.73 | $47.99(15.00% Upside) | $7.34B | 0.21% | 73Outperform |
 VOOV | $230.90 | $262.50(13.69% Upside) | $6.92B | 0.07% | 72Outperform |
 IWX | $113.81 | $128.99(13.34% Upside) | $3.88B | 0.20% | 73Outperform |
 FELV | $42.98 | $48.98(13.97% Upside) | $3.64B | 0.18% | 72Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| RPV | Invesco S&P 500 Pure Value ETF | 120.25 | 22.94 | 23.57% | |
| JAVA | JPMorgan Active Value ETF | 82.94 | 14.39 | 20.99% | |
| DFLV | Dimensional US Large Cap Value ETF | 41.73 | 9.38 | 29.00% | |
| VOOV | Vanguard S&P 500 Value ETF | 230.90 | 32.32 | 16.27% | |
| IWX | iShares Russell Top 200 Value ETF | 113.81 | 26.14 | 29.82% | |
| FELV | Fidelity Enhanced Large Cap Value ETF | 42.98 | 9.88 | 29.83% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.